Bioimpedance analysis (BIA) is a validated non-invasive technique already proven to be useful for the diagnosis, prognosis, and management of body fluids in subjects with heart failure (HF) and chronic kidney disease (CKD). Although BIA has been widely employed for research purposes, its clinical application is still not fully widespread. The aim of this review is to provide a comprehensive overview of the state of the art of BIA utilization by analyzing the clinical benefits, limitations, and potential future developments in this clinically unexplored field.
Bioimpedance Analysis in CKD and HF Patients: A Critical Review of Benefits, Limitations, and Future Directions / La Porta, Edoardo; Faragli, Alessandro; Herrmann, Alexander; Lo Muzio, Francesco Paolo; Estienne, Luca; Nigra, Stefano Geniere; Bellasi, Antonio; Deferrari, Giacomo; Ricevuti, Giovanni; Di Somma, Salvatore; Alogna, Alessio. - In: JOURNAL OF CLINICAL MEDICINE. - ISSN 2077-0383. - 13:21(2024). [10.3390/jcm13216502]
Bioimpedance Analysis in CKD and HF Patients: A Critical Review of Benefits, Limitations, and Future Directions
Lo Muzio, Francesco Paolo;
2024-01-01
Abstract
Bioimpedance analysis (BIA) is a validated non-invasive technique already proven to be useful for the diagnosis, prognosis, and management of body fluids in subjects with heart failure (HF) and chronic kidney disease (CKD). Although BIA has been widely employed for research purposes, its clinical application is still not fully widespread. The aim of this review is to provide a comprehensive overview of the state of the art of BIA utilization by analyzing the clinical benefits, limitations, and potential future developments in this clinically unexplored field.I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
